Biopharmaceuticals Market Growth: Worth $700Bn by 2028 Led by Monoclonal Antibodies Held Market Share of 48.42% in 2022 | The Insight Partners
March 23, 2023 08:46 ET
|
The Insight Partners
New York, March 23, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Biopharmaceuticals Market Size, Share, Trends, Growth and Report Forecasts to 2028 - COVID-19 Impact and Global...
Medical Styrenic Polymer Market Projected to Expand at a CAGR of 5.7% from 2023 to 2030, According to Contrive Datum Insights
March 19, 2023 00:00 ET
|
Contrive Datum Insights Pvt Ltd
Farmington, March 19, 2023 (GLOBE NEWSWIRE) -- The Medical Styrenic Polymers Market is anticipated to progress at a CAGR of 5.7% during the forecast period 2022-2030. Polyvinyl chloride, or PVC, is...
Aridis Reports Top-Line Results of the Phase 3 Double-Blinded, Superiority Trial of AR-301 For the Treatment of Staphylococcus aureus Ventilator Associated Pneumonia (VAP)
January 25, 2023 16:05 ET
|
Aridis Pharmaceuticals, Inc.
LOS GATOS, Calif, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) today announced top-line results from the AR-301-002 Phase 3 study, which evaluated the superiority of...
Aridis Pharmaceuticals to Discuss Topline Data from Phase 3 Study of AR-301 During Corporate Update Call on January 25
December 28, 2022 08:30 ET
|
Aridis Pharmaceuticals, Inc.
Los Gatos, Calif., Dec. 28, 2022 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective...
Biologics Market Size is projected to reach USD 506 Billion by 2030, growing at a CAGR of 4%: Straits Research
June 23, 2022 09:15 ET
|
Straits Research
New York, United States, June 23, 2022 (GLOBE NEWSWIRE) -- The market for biologics is growing steadily because companies are spending a lot of money to improve the places where they make their...
Alzheimer’s Patient Advocates File FOIA Seeking Answers on Discriminatory Medicare Coverage Decision
April 15, 2022 11:42 ET
|
UsAgainstAlzheimer's
Washington, D.C., April 15, 2022 (GLOBE NEWSWIRE) -- Today, UsAgainstAlzheimer’s announced their latest effort to demand answers from the Centers for Medicare and Medicare Services (CMS) about last...
Antibody Therapy Market Revenue to hit $445 Billion by 2028, Says Global Market Insights Inc.
February 22, 2022 03:00 ET
|
Global Market Insights Inc.
Selbyville, Delaware, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Global antibody therapy market value projected to cross USD 445 billion by 2028, according to a new research report by Global Market...
Symphogen publishes discovery and pre-clinical data on first chicken-derived antibody to enter human clinical trials
May 16, 2019 00:59 ET
|
Symphogen A/S
Sym021 a novel anti-PD1 compound currently in Phase 1 clinical trials Copenhagen, 16 May 2019 – Symphogen, a private clinical stage oncology focused biopharmaceutical company with a productive...
Antibody Drug Market Expected to Gain $30 Billion Through 2022
October 03, 2017 14:30 ET
|
BCC Research
WELLESLEY, Mass. , Oct. 03, 2017 (GLOBE NEWSWIRE) -- An increase in research and development, burgeoning industry competition and evolving technologies are steering the antibody drug market into a...